AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
Selecta Biosciences and AskBio receives US FDA rare pediatric disease designation for their gene therapy for methylmalonic acidemia ... Oct 21
-Advertisements-